These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Kolibianakis EM; Schultze-Mosgau A; Schroer A; van Steirteghem A; Devroey P; Diedrich K; Griesinger G Hum Reprod; 2005 Oct; 20(10):2887-92. PubMed ID: 15979994 [TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response. De Placido G; Mollo A; Clarizia R; Strina I; Conforti S; Alviggi C Fertil Steril; 2006 Jan; 85(1):247-50. PubMed ID: 16412769 [TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer. Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156 [TBL] [Abstract][Full Text] [Related]
10. [Onset and maintenance of the luteal phase with GnRH agonists or hCG in cycles under GnRH antagonists]. Olivennes F J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S24-6. PubMed ID: 15643682 [TBL] [Abstract][Full Text] [Related]
11. Are GnRH antagonists comparable to agonists for use in IVF? Huirne JA; Homburg R; Lambalk CB Hum Reprod; 2007 Nov; 22(11):2805-13. PubMed ID: 17872909 [TBL] [Abstract][Full Text] [Related]
12. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study. Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439 [TBL] [Abstract][Full Text] [Related]
13. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues? Orvieto R; Meltzer S; Rabinson J; Gemer O; Anteby EY; Nahum R Fertil Steril; 2008 Oct; 90(4):1297-300. PubMed ID: 18249369 [TBL] [Abstract][Full Text] [Related]
14. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes. Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961 [TBL] [Abstract][Full Text] [Related]
15. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344 [TBL] [Abstract][Full Text] [Related]
16. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197 [TBL] [Abstract][Full Text] [Related]
17. GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry. Griesinger G; Felberbaum R; Diedrich K Hum Reprod; 2005 Sep; 20(9):2373-5. PubMed ID: 15932915 [TBL] [Abstract][Full Text] [Related]
18. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Griesinger G; Kolibianakis EM; Papanikolaou EG; Diedrich K; Van Steirteghem A; Devroey P; Ejdrup Bredkjaer H; Humaidan P Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691 [TBL] [Abstract][Full Text] [Related]